Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1224 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pitolisant for treating narcolepsy in children and adolescents Pitolisant (Wakix;BF 2649) Narcolepsy Neurology 2023 View  |  Download
Plinabulin in addition to docetaxel for advanced, metastatic non-small-cell lung cancer - second line or greater Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Plinabulin (BPI-2358) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Plinabulin in combination with G-CSF for chemotherapy-induced neutropenia Plinabulin (BPI-2358) Chemotherapy-induced neutropenia Immunology , Toxicology 2020 View  |  Download
PLX-PAD for Critical Limb Ischaemia (with minor tissue loss) in Patients Unsuitable for Revascularisation PLX-PAD Critical limb ischaemia (CLI) Cardiovascular System 2018 View  |  Download
PLX-PAD for injured gluteal musculature following arthroplasty PLX-PAD Injured gluteal musculature Musculoskeletal System 2021 View  |  Download
Polatuzumab vedotin in addition to R-CHP for diffuse large B-cell lymphoma – first line Chemotherapy , Polatuzumab vedotin (DCDS4501A; RG7596; RG-7596; Polivy) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2020 View  |  Download
Polatuzumab vedotin in combination with rituximab and bendamustine for the treatment of diffuse large B-cell lymphoma Bendamustine (Treanda; EP-3102; Levact; Ribomustin; bendamustine hydrochloride monohydrate; bendamustine hydrochloride) , Polatuzumab vedotin (DCDS4501A; RG7596; RG-7596; Polivy) , Rituximab (MabThera; Rituxan; RG 105) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2018 View  |  Download
Pomalidomide (Imnovid) with bortezomib and dexamethasone for relapsed or refractory multiple myeloma‐ second line and beyond Bortezomib (Velcade; bortezomib mannitol boronic ester) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2017 View  |  Download
Ponatinib for chronic myeloid leukaemia in paediatric patients Ponatinib (AP24534) Chronic myeloid leukaemia (CML) Haematological Cancer and Lymphomas 2024 View  |  Download
Ponesimod for Relapsing-remitting Multiple Sclerosis Ponesimod (ACT-128800; RG-3477) Multiple sclerosis (MS) Neurology 2017 View  |  Download
1 2 86 87 88 89 90 122 123
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications